Corneal endothelial cell density in patients receiving chemotherapy

References

• Eye Bank Association of America. EBAA eye banking statistical report. 2020. Available from: www.restoresight.org
   Google Scholar
• Park CY, Lee JK, Gore PK, et al. Keratoplasty in the United States: a 10-year review from 2005 through 2014. Ophthalmology 2015;122:2432–2442.
   PubMed Web of Science ®Google Scholar
• Price FW, Jr, Feng MT, Price MO. Evolution of endothelial keratoplasty: where are we headed? Cornea 2015;34:S41–S47.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Lass JH, Szczotka-Flynn LB, Ayala AR, et al. Cornea preservation time study: methods and potential impact on the cornea donor pool in the United States. Cornea 2015;34:601–608.
   PubMed Web of Science ®Google Scholar
• Sugar J, Montoya M, Dontchev M, et al. Donor risk factors for graft failure in the cornea donor study. Cornea 2009;28:981–985.
   PubMed Web of Science ®Google Scholar
• Sugar A, Gal RL, Kollman C, et al. Factors associated with corneal graft survival in the cornea donor study. JAMA Ophthalmol 2015;133:246–254.
   PubMed Web of Science ®Google Scholar
• Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001;108:1134–1139.
   PubMed Web of Science ®Google Scholar
• Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002;109:1709–1716.
   PubMed Web of Science ®Google Scholar
• Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 2008;92:383–388.
   PubMed Web of Science ®Google Scholar
• Gorovoy I, Prechanond T, Abia M, et al. Toxic corneal epitheliopathy after intravitreal methotrexate and its treatment with oral folic acid. Cornea 2013;32:1171–1173.
   PubMed Web of Science ®Google Scholar
• Jeong Y, Ryu JS, Park UC, Oh JY. Corneal epithelial toxicity after intravitreal methotrexate injection for vitreoretinal lymphoma: clinical and in vitro studies. J Clin Med 2020;9(8): doi:10.3390/jcm9082672.
   Web of Science ®Google Scholar
• Ghasemi Falavarjani K, Golabi S, Hadavandkhani A. Effect of intravitreal injection of methotrexate on human corneal endothelial cells. Cornea 2016;35:217–219.
   PubMed Web of Science ®Google Scholar
• Schmid KE, Kornek GV, Scheithauer W, Binder S. Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 2006;51:19–40.
   PubMed Web of Science ®Google Scholar
• Harman LE. Ophthalmic complications related to chemotherapy in medically complex patients. Cancer Control 2016;23:150–156.
   PubMed Web of Science ®Google Scholar
• Zinchuk O, Watanabe M, Hayashi N, et al. A case of tamoxifen keratopathy. Arch Ophthalmol 2006;124:1046–1048.
   PubMedGoogle Scholar
• Papathanassiou M, Nikita E, Theodossiadis P, et al. Exemestane-induced corneal epithelial changes. Cutan Ocul Toxicol 2010;29:209–211.
   PubMed Web of Science ®Google Scholar
• Karamitsos A, Kokkas V, Goulas A, et al. Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen. Hippokratia 2013;17:120–125.
   PubMed Web of Science ®Google Scholar
• Kau H-C, Tsai C-C. Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis. Cutan Ocul Toxicol 2016;35:257–259.
   PubMed Web of Science ®Google Scholar
• Hsiao C-C, Yao M, Liu J-H, Chen W-L. Pembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantation. Clin Exp Ophthalmol 2018;46:698–700.
   PubMed Web of Science ®Google Scholar
• Kiratli H, Aygün FB, Gedikoğlu G. Corneal relapse of peripheral T-cell lymphoma under systemic chemotherapy. Cornea 2018;37:1593–1595.
   PubMed Web of Science ®Google Scholar
• Kuriki R, Hata T, Nakayama K, et al. Tegafur and 5-fluorouracil levels in tears and changes in tear volume in long-term users of the oral anticancer drug S-1. Nagoya J Med Sci 2019;81:415–425.
   PubMed Web of Science ®Google Scholar
• Van Meter WS. Central corneal opacification resulting from recent chemotherapy in corneal donors. T Am Ophthalmol Soc 2007;105:207–212.
   PubMedGoogle Scholar
• McCarey BE, Edelhauser HF, Lynn MJ. Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea 2008;27:1–16.
   PubMed Web of Science ®Google Scholar
• Benetz BA, Gal RL, Ruedy KJ, et al. Specular microscopy ancillary study methods for donor endothelial cell density determination of cornea donor study images. Curr Eye Res 2006;31:319–327.
   PubMed Web of Science ®Google Scholar
• QuickFacts, Lancaster County, Pennsylvania. United States Census Bureau. 2020. Available from: https://www.census.gov/quickfacts/fact/table/lancastercountypennsylvania/PST040219
   Google Scholar
• Philips C, Laing R, Yee R. Specular Microscopy. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea, volume one: fundamentals, diagnosis, and management. 2nd ed. Amsterdam (The Netherlands): Elsevier Inc.; 2005.
   Google Scholar
• Jones SS, Azar RG, Cristol SM, et al. Effects of laser in situ keratomileusis (LASIK) on the corneal endothelium. Am J Ophthalmol 1998;125:465–471.
   PubMed Web of Science ®Google Scholar
• Redbrake C, Sieben P, Salla S, Reim M. [Effect of donor illness on endothelial cell number of human corneas]. Klin Monatsbl Augenh 1995;206:46–48.
   PubMed Web of Science ®Google Scholar
• Deb-Joardar N, Thuret G, Dumollard J-M, et al. Experimental study of the survival of metastatic cancer cells in corneal organ culture. Invest Ophth Vis Sci 2006;47:1339–1347.
   PubMed Web of Science ®Google Scholar
• Yao X, Lee M, Ying F, et al. Transplanted corneal graft with metastatic cholangiocarcinoma to the donor eye. Eye Contact Lens 2008;34:340–342.
   PubMed Web of Science ®Google Scholar
• Margo CE, Murtagh FR. Ocular and orbital toxicity after intracarotid cisplatin therapy. Am J Ophthalmol 1993;116:508–509.
   PubMed Web of Science ®Google Scholar
• Grimson BS, Mahaley MS, Jr, Dubey HD, Dudka L. Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine). J Clin Neuro-Ophthal 1981;1:261–264.
   PubMedGoogle Scholar
• Watanabe W, Kuwabara R, Nakahara T, et al. Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas. Graefes Arch Clin Exp Ophthalmol 2002;240:1033–1035.
   PubMed Web of Science ®Google Scholar
• Krohn J, Høvding G. The influence of donor age and cause of death on corneal endothelial cell density. Acta Ophthalmol Scan 2005;83:746–750.
   PubMedGoogle Scholar
• Maruoka S, Nakakura S, Matsuo N, et al. Comparison of semi-automated center-dot and fully automated endothelial cell analyses from specular microscopy images. Int Ophthalmol 2018;38:2495–2507.
   PubMed Web of Science ®Google Scholar
• Nichols JJ, Kosunick GM, Bullimore MA. Reliability of corneal thickness and endothelial cell density measures. J Refract Surg 2003;19:344–352.
   PubMed Web of Science ®Google Scholar